相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunoprofiling of patients with chronic myeloid leukemia at diagnosis and during tyrosine kinase inhibitor therapy
Peter Rohon et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis
Fabrizio Vianello et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Choosing the best treatment strategy for chronic myeloid leukemia patients resistant to imatinib: weighing the efficacy and safety of individual drugs with BCR-ABL mutations and patient history
E. Jabbour et al.
LEUKEMIA (2010)
Abnormal phenotype of bone marrow plasma cells in patients with chronic myeloid leukemia undergoing therapy with Imatinib
Giovanni Carulli et al.
LEUKEMIA RESEARCH (2010)
Efficacy of Imatinib Dose Escalation in Patients With Chronic Myeloid Leukemia in Chronic Phase
Hagop M. Kantarjian et al.
CANCER (2009)
Effects of imatinib mesylate in osteoblastogenesis
Daniele Tibullo et al.
EXPERIMENTAL HEMATOLOGY (2009)
Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia
A. Hochhaus et al.
LEUKEMIA (2009)
Cytotoxic natural antibodies against human tumours:: An option for anti-cancer immunotherapy?
Reinhard Schwartz-Albiez et al.
AUTOIMMUNITY REVIEWS (2008)
A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer
Shangxin Yang et al.
CANCER RESEARCH (2008)
Part I: Mechanisms of resistance to imatinib in chronic myeloid leukaemia
Jane F. Apperley
LANCET ONCOLOGY (2007)
CD5+ B cells with the features of subepithelial B cells found in human tonsils
Mariella Dono et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Chronic myeloid leukaemia
Ruediger Hehlmann et al.
LANCET (2007)
Imatinib mesylate inhibits proliferation and modulates cytokine expression of human cancer-associated stromal fibroblasts from colorectal metastases
Lars Mueller et al.
CANCER LETTERS (2007)
VCAM-1-positive stromal cells from human bone marrow producing cytokines for B lineage progenitors and for plasma cells: SDF-1, flt3L, and BAFF
Daniel H. S. Schaumann et al.
MOLECULAR IMMUNOLOGY (2007)
Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR
Simone Fleige et al.
BIOTECHNOLOGY LETTERS (2006)
Anti-αGal-dependent complement-mediated cytotoxicity in metastatic melanoma
JMG Larkin et al.
MELANOMA RESEARCH (2006)
Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity
CW Chan et al.
NATURE MEDICINE (2006)
IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells
R Ettinger et al.
JOURNAL OF IMMUNOLOGY (2005)
Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells
G Muehlinghaus et al.
BLOOD (2005)
Bone marrow endothelial cells in multiple myeloma secrete CXC-chemokines that mediate interactions with plasma cells
A Pellegrino et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Imatinib therapy in chronic myelogenous leukemia:: strategies to avoid and overcome resistance
A Hochhaus et al.
LEUKEMIA (2004)
Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of blimp-1 and bcl-61
K Ozaki et al.
JOURNAL OF IMMUNOLOGY (2004)
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia -: A Europe Against Cancer Program
J Gabert et al.
LEUKEMIA (2003)
The effects of STI571 on antigen presentation of dendritic cells generated from patients with chronic myelogenous leukemia
N Sato et al.
HEMATOLOGICAL ONCOLOGY (2003)
Crosstalk between BCR/ABL oncoprotein and CXCR4 signaling through a Src family kinase in human leukemia cells
A Ptasznik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation
MS Holtz et al.
BLOOD (2002)
B1 cells: similarities and differences with other B cell subsets
F Martin et al.
CURRENT OPINION IN IMMUNOLOGY (2001)
Synthesis and release of B-lymphocyte stimulator from myeloid cells
B Nardelli et al.
BLOOD (2001)
Biological effects of stroma-derived factor-1α on normal and CML CD34+ haemopoietic cells
J Dürig et al.
LEUKEMIA (2000)
分享论文
